EUVIMEDScopri EUVIMED
Crossref

Efficacy of Glucocorticoids in the Treatment of Retinal Detachment With Choroidal Detachment: Analysis by Proteomics

Pingping Li iD, Mengyao Han, Rui Zhang, Fangyu Chen, Yanzi Li, Jing Yuan, Ning Ma, Lu Li iD, Jianhua Wu

PROTEOMICS – Clinical Applications · 2025

DOI: 10.1002/prca.70008 ↗

At a glance

Journal article in PROTEOMICS – Clinical Applications, 2025. Written by Pingping Li and 8 co-authors. Institution: Department of Aier Eye Hospital of Wuhan University, Wuhan, China. Major MEDLINE topics: Choroidal Effusions, Glucocorticoids, Retinal Detachment, Anti-Inflammatory Agents. 52 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Purpose

Glucocorticoids are widely used for their anti‐inflammatory properties, but their specific molecular mechanisms in treating rhegmatogenous retinal detachment with choroidal detachment (RRDCD) remain unclear. This study aims to identify key regulatory factors in the vitreous humor of RRDCD patients and analyze protein changes after hormonal intervention.

Methods

Vitreous fluid samples were collected during surgery from patients with rhegmatogenous retinal detachment (RRD, n = 40), non‐glucocorticoid treated RRDCD (nT‐RRDCD, n = 35), and glucocorticoid‐treated RRDCD (T‐RRDCD, n = 32). Primary outcomes were retinal reattachment status and best‐corrected visual acuity (BCVA) at 6 months postoperatively. Proteomic analysis was performed using data‐independent acquisition (DIA), with differentially expressed proteins validated by parallel reaction monitoring (PRM) and ELISA.

Results

Between RRD and nT‐RRDCD, 203 differentially expressed proteins were identified, while 295 proteins were differentially expressed between nT‐RRDCD and T‐RRDCD. These proteins were involved in complement activation, immune response, blood coagulation, and MAPK signaling. Apolipoprotein D (APOD) and vitronectin (VTN) positively correlated with postoperative BCVA. APOD, serum amyloid A‐4 (SAA4), and ubiquitin‐conjugating enzyme E2 variant emerged as potential diagnostic biomarkers for RRDCD.

Conclusions

RRDCD development involves multiple factors. Glucocorticoids mitigate retinal damage by suppressing inflammation, regulating oxidative stress, and promoting cell repair. APOD and VTN correlate with BCVA, while APOD, SAA4, and ubiquitin‐conjugating enzyme E2 show promise as diagnostic biomarkers for RRDCD.

Subjects

MeSH terms (MEDLINE)

Choroidal EffusionsGlucocorticoidsRetinal DetachmentAnti-Inflammatory AgentsAdultAgedFemaleHumansMaleMiddle AgedFollow-Up StudiesMAP Kinase Signaling SystemOxidative StressProtein Interaction MapsProteomeProteomicsVitreous Body

Author keywords

biomarkerschoroidal detachmentglucocorticoids therapyinflammationquantitative proteomicsretinal detachment

Substances

GlucocorticoidsProteomeAnti-Inflammatory Agents

Authors and institutions

  • Department of Aier Eye Hospital of Wuhan University, Wuhan, China.
  • Department of Eye Center, Renmin Hospital of Wuhan University, Wuhan, China.

ORCID profiles: Pingping Li, Lu Li

Cite

APA

Li, P., Han, M., Zhang, R., Chen, F., Li, Y., Yuan, J., Ma, N., Li, L., & Wu, J. (2025). Efficacy of Glucocorticoids in the Treatment of Retinal Detachment With Choroidal Detachment: Analysis by Proteomics. PROTEOMICS – Clinical Applications. https://doi.org/10.1002/prca.70008

Vancouver

Li P, Han M, Zhang R, Chen F, Li Y, Yuan J, et al. Efficacy of Glucocorticoids in the Treatment of Retinal Detachment With Choroidal Detachment: Analysis by Proteomics. PROTEOMICS – Clinical Applications. 2025. doi:10.1002/prca.70008

BibTeX
@article{Li2025,
  author = {Li, Pingping and Han, Mengyao and Zhang, Rui and Chen, Fangyu and Li, Yanzi and Yuan, Jing and Ma, Ning and Li, Lu and Wu, Jianhua},
  title = {Efficacy of Glucocorticoids in the Treatment of Retinal Detachment With Choroidal Detachment: Analysis by Proteomics},
  journal = {PROTEOMICS – Clinical Applications},
  year = {2025},
  doi = {10.1002/prca.70008}
}
Start for free →